APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Equine Pharmaceuticals and Supplements

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Selected research

Market Outlook & Growth Opportunities

Global Equine Pharmaceuticals and Supplements Market Outlook and Growth Opportunities 2026

Report ID 173989140421 December 2025190 pages

Choose your research edition.

Industry ResearchEquine Pharmaceuticals and Supplements Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Pharmaceuticals and Supplements Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Equine Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Pharmaceuticals and Supplements Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Pharmaceuticals and Supplements Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.

North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.

Read the full market overview

In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.

This report provides an overview of the global Equine Pharmaceuticals and Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Equine Pharmaceuticals and Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Equine Pharmaceuticals and Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Equine Pharmaceuticals and Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Equine Pharmaceuticals and Supplements Segment by Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Equine Pharmaceuticals and Supplements Segment by Type

Pharmaceuticals

Supplements

Equine Pharmaceuticals and Supplements Segment by Application

Thoroughbred Horse

Other Types of Horses

Equine Pharmaceuticals and Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Equine Pharmaceuticals and Supplements status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Equine Pharmaceuticals and Supplements market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Equine Pharmaceuticals and Supplements significant trends, drivers, influence factors in global and regions.

6. To analyze Equine Pharmaceuticals and Supplements competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Pharmaceuticals and Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Equine Pharmaceuticals and Supplements market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Equine Pharmaceuticals and Supplements industry.

Chapter 3: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Equine Pharmaceuticals and Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Equine Pharmaceuticals and Supplements in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Equine Pharmaceuticals and Supplements Industry Trends Table 2. Equine Pharmaceuticals and Supplements Industry Drivers Table 3. Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges Table 4. Equine Pharmaceuticals and Supplements Industry Restraints Table 5. Global Equine Pharmaceuticals and Supplements Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Equine Pharmaceuticals and Supplements Revenue Share by Company (2021-2026) Table 7. Global Equine Pharmaceuticals and Supplements Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Equine Pharmaceuticals and Supplements Sales Volume Share by Company (2021-2026) Table 9. Global Equine Pharmaceuticals and Supplements Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Equine Pharmaceuticals and Supplements Company Ranking, (2024-2026) & (USD Million) Table 11. Global Equine Pharmaceuticals and Supplements Key Company Manufacturing Base & Headquarters Table 12. Global Equine Pharmaceuticals and Supplements Company, Product Type & Application Table 13. Global Equine Pharmaceuticals and Supplements Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pharmaceuticals Table 18. Significant Companies of Supplements Table 19. Global Equine Pharmaceuticals and Supplements Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Equine Pharmaceuticals and Supplements Sales Volume Share by Type (2021-2026) Table 23. Global Equine Pharmaceuticals and Supplements Sales Volume Share by Type (2027-2032) Table 24. Global Equine Pharmaceuticals and Supplements Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Equine Pharmaceuticals and Supplements Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Equine Pharmaceuticals and Supplements Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Equine Pharmaceuticals and Supplements Sales Value Share by Type (2021-2026) Table 28. Global Equine Pharmaceuticals and Supplements Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Thoroughbred Horse Table 30. Significant Companies of Other Types of Horses Table 31. Global Equine Pharmaceuticals and Supplements Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Equine Pharmaceuticals and Supplements Sales Volume Share by Application (2021-2026) Table 35. Global Equine Pharmaceuticals and Supplements Sales Volume Share by Application (2027-2032) Table 36. Global Equine Pharmaceuticals and Supplements Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Equine Pharmaceuticals and Supplements Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Equine Pharmaceuticals and Supplements Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Equine Pharmaceuticals and Supplements Sales Value Share by Application (2021-2026) Table 40. Global Equine Pharmaceuticals and Supplements Sales Value Share by Application (2027-2032) Table 41. Global Equine Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units) Table 43. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021-2026) Table 44. Global Equine Pharmaceuticals and Supplements Sales by Region (2027-2032) & (K Units) Table 45. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2027-2032) Table 46. Global Equine Pharmaceuticals and Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Equine Pharmaceuticals and Supplements Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Equine Pharmaceuticals and Supplements Sales Value Share by Region (2021-2026) Table 49. Global Equine Pharmaceuticals and Supplements Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Equine Pharmaceuticals and Supplements Sales Value Share by Region (2027-2032) Table 51. Global Equine Pharmaceuticals and Supplements Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Equine Pharmaceuticals and Supplements Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Equine Pharmaceuticals and Supplements Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Equine Pharmaceuticals and Supplements Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 56. Global Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021-2026) Table 57. Global Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 58. Global Equine Pharmaceuticals and Supplements Sales Market Share by Country (2027-2032) Table 59. Global Equine Pharmaceuticals and Supplements Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Equine Pharmaceuticals and Supplements Sales Value Market Share by Country (2021-2026) Table 61. Global Equine Pharmaceuticals and Supplements Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Equine Pharmaceuticals and Supplements Sales Value Market Share by Country (2027-2032) Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio Table 67. Boehringer Ingelheim Recent Development Table 68. Merck Animal Health Company Information Table 69. Merck Animal Health Business Overview Table 70. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 72. Merck Animal Health Recent Development Table 73. Zoetis Company Information Table 74. Zoetis Business Overview Table 75. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Zoetis Equine Pharmaceuticals and Supplements Product Portfolio Table 77. Zoetis Recent Development Table 78. Bayer Animal Health Company Information Table 79. Bayer Animal Health Business Overview Table 80. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 82. Bayer Animal Health Recent Development Table 83. Elanco Animal Health Company Information Table 84. Elanco Animal Health Business Overview Table 85. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 87. Elanco Animal Health Recent Development Table 88. Dechra Veterinary Products Company Information Table 89. Dechra Veterinary Products Business Overview Table 90. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio Table 92. Dechra Veterinary Products Recent Development Table 93. CEVA Company Information Table 94. CEVA Business Overview Table 95. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. CEVA Equine Pharmaceuticals and Supplements Product Portfolio Table 97. CEVA Recent Development Table 98. Virbac Company Information Table 99. Virbac Business Overview Table 100. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Virbac Equine Pharmaceuticals and Supplements Product Portfolio Table 102. Virbac Recent Development Table 103. Norbrook Equine Company Information Table 104. Norbrook Equine Business Overview Table 105. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio Table 107. Norbrook Equine Recent Development Table 108. Kyoritsu Seiyaku Company Information Table 109. Kyoritsu Seiyaku Business Overview Table 110. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio Table 112. Kyoritsu Seiyaku Recent Development Table 113. Vetoquinol Company Information Table 114. Vetoquinol Business Overview Table 115. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio Table 117. Vetoquinol Recent Development Table 118. Protexin Healthcare Company Information Table 119. Protexin Healthcare Business Overview Table 120. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio Table 122. Protexin Healthcare Recent Development Table 123. Audevard Company Information Table 124. Audevard Business Overview Table 125. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Audevard Equine Pharmaceuticals and Supplements Product Portfolio Table 127. Audevard Recent Development Table 128. Ouro Fino Saude Company Information Table 129. Ouro Fino Saude Business Overview Table 130. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio Table 132. Ouro Fino Saude Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Equine Pharmaceuticals and Supplements Distributors List Table 136. Equine Pharmaceuticals and Supplements Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Equine Pharmaceuticals and Supplements Product Image Figure 2. Global Equine Pharmaceuticals and Supplements Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Pharmaceuticals and Supplements Sales Value (2021-2032) & (US$ Million) Figure 4. Global Equine Pharmaceuticals and Supplements Sales (2021-2032) & (K Units) Figure 5. Global Equine Pharmaceuticals and Supplements Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Equine Pharmaceuticals and Supplements Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pharmaceuticals Image Figure 10. Supplements Image Figure 11. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Equine Pharmaceuticals and Supplements Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Equine Pharmaceuticals and Supplements Sales Volume Share by Type (2021-2032) Figure 14. Global Equine Pharmaceuticals and Supplements Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Equine Pharmaceuticals and Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Equine Pharmaceuticals and Supplements Sales Value Share by Type (2021-2032) Figure 17. Thoroughbred Horse Image Figure 18. Other Types of Horses Image Figure 19. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Equine Pharmaceuticals and Supplements Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Equine Pharmaceuticals and Supplements Sales Volume Share by Application (2021-2032) Figure 22. Global Equine Pharmaceuticals and Supplements Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Equine Pharmaceuticals and Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Equine Pharmaceuticals and Supplements Sales Value Share by Application (2021-2032) Figure 25. Global Equine Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Equine Pharmaceuticals and Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Equine Pharmaceuticals and Supplements Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Equine Pharmaceuticals and Supplements Sales Value (2021-2032) & (US$ Million) Figure 30. North America Equine Pharmaceuticals and Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Equine Pharmaceuticals and Supplements Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Equine Pharmaceuticals and Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Equine Pharmaceuticals and Supplements Sales Value (2021-2032) & (US$ Million) Figure 36. South America Equine Pharmaceuticals and Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Equine Pharmaceuticals and Supplements Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Equine Pharmaceuticals and Supplements Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Supplements
Applications
  • Thoroughbred Horse
  • Other Types of Horses
Companies covered
  • Boehringer Ingelheim
  • Merck Animal Health
  • Zoetis
  • Bayer Animal Health
  • Elanco Animal Health
  • Dechra Veterinary Products
  • CEVA
  • Virbac
  • Norbrook Equine
  • Kyoritsu Seiyaku
  • Vetoquinol
  • Protexin Healthcare
  • Audevard
  • Ouro Fino Saude

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Equine Pharmaceuticals and Supplements Sales Value (2021-2032)
  4. 1.2.2 Global Equine Pharmaceuticals and Supplements Sales Volume (2021-2032)
  5. 1.2.3 Global Equine Pharmaceuticals and Supplements Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Equine Pharmaceuticals and Supplements Market Dynamics
  1. 2.1 Equine Pharmaceuticals and Supplements Industry Trends
  2. 2.2 Equine Pharmaceuticals and Supplements Industry Drivers
  3. 2.3 Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges
  4. 2.4 Equine Pharmaceuticals and Supplements Industry Restraints
3 Equine Pharmaceuticals and Supplements Market by Company
  1. 3.1 Global Equine Pharmaceuticals and Supplements Company Revenue Ranking in 2025
  2. 3.2 Global Equine Pharmaceuticals and Supplements Revenue by Company (2021-2026)
  3. 3.3 Global Equine Pharmaceuticals and Supplements Sales Volume by Company (2021-2026)
  4. 3.4 Global Equine Pharmaceuticals and Supplements Average Price by Company (2021-2026)
  5. 3.5 Global Equine Pharmaceuticals and Supplements Company Ranking (2024-2026)
  6. 3.6 Global Equine Pharmaceuticals and Supplements Company Manufacturing Base and Headquarters
  7. 3.7 Global Equine Pharmaceuticals and Supplements Company Product Type and Application
  8. 3.8 Global Equine Pharmaceuticals and Supplements Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Equine Pharmaceuticals and Supplements Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Equine Pharmaceuticals and Supplements Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Equine Pharmaceuticals and Supplements Market by Type
  1. 4.1 Equine Pharmaceuticals and Supplements Type Introduction
  2. 4.1.1 Pharmaceuticals
  3. 4.1.2 Supplements
  4. 4.2 Global Equine Pharmaceuticals and Supplements Sales Volume by Type
  5. 4.2.1 Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Equine Pharmaceuticals and Supplements Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Equine Pharmaceuticals and Supplements Sales Value by Type
  9. 4.3.1 Global Equine Pharmaceuticals and Supplements Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Equine Pharmaceuticals and Supplements Sales Value by Type (2021-2032)
  11. 4.3.3 Global Equine Pharmaceuticals and Supplements Sales Value Share by Type (2021-2032)
5 Equine Pharmaceuticals and Supplements Market by Application
  1. 5.1 Equine Pharmaceuticals and Supplements Application Introduction
  2. 5.1.1 Thoroughbred Horse
  3. 5.1.2 Other Types of Horses
  4. 5.2 Global Equine Pharmaceuticals and Supplements Sales Volume by Application
  5. 5.2.1 Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Equine Pharmaceuticals and Supplements Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Equine Pharmaceuticals and Supplements Sales Value by Application
  9. 5.3.1 Global Equine Pharmaceuticals and Supplements Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Equine Pharmaceuticals and Supplements Sales Value by Application (2021-2032)
  11. 5.3.3 Global Equine Pharmaceuticals and Supplements Sales Value Share by Application (2021-2032)
6 Equine Pharmaceuticals and Supplements Regional Sales and Value Analysis
  1. 6.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2032)
  3. 6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021-2026
  4. 6.2.2 Global Equine Pharmaceuticals and Supplements Sales by Region (2027-2032)
  5. 6.3 Global Equine Pharmaceuticals and Supplements Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Equine Pharmaceuticals and Supplements Sales Value by Region (2021-2032)
  7. 6.4.1 Global Equine Pharmaceuticals and Supplements Sales Value by Region: 2021-2026
  8. 6.4.2 Global Equine Pharmaceuticals and Supplements Sales Value by Region (2027-2032)
  9. 6.5 Global Equine Pharmaceuticals and Supplements Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Equine Pharmaceuticals and Supplements Sales Value (2021-2032)
  12. 6.6.2 North America Equine Pharmaceuticals and Supplements Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Equine Pharmaceuticals and Supplements Sales Value (2021-2032)
  15. 6.7.2 Europe Equine Pharmaceuticals and Supplements Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Equine Pharmaceuticals and Supplements Sales Value (2021-2032)
  21. 6.9.2 South America Equine Pharmaceuticals and Supplements Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Value Share by Country, 2025 VS 2032
7 Equine Pharmaceuticals and Supplements Country-level Sales and Value Analysis
  1. 7.1 Global Equine Pharmaceuticals and Supplements Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Equine Pharmaceuticals and Supplements Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Equine Pharmaceuticals and Supplements Sales by Country (2021-2032)
  4. 7.3.1 Global Equine Pharmaceuticals and Supplements Sales by Country (2021-2026)
  5. 7.3.2 Global Equine Pharmaceuticals and Supplements Sales by Country (2027-2032)
  6. 7.4 Global Equine Pharmaceuticals and Supplements Sales Value by Country (2021-2032)
  7. 7.4.1 Global Equine Pharmaceuticals and Supplements Sales Value by Country (2021-2026)
  8. 7.4.2 Global Equine Pharmaceuticals and Supplements Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Equine Pharmaceuticals and Supplements Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Equine Pharmaceuticals and Supplements Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Equine Pharmaceuticals and Supplements Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Merck Animal Health
  8. 8.2.1 Merck Animal Health Company Information
  9. 8.2.2 Merck Animal Health Business Overview
  10. 8.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  12. 8.2.5 Merck Animal Health Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Bayer Animal Health
  20. 8.4.1 Bayer Animal Health Company Information
  21. 8.4.2 Bayer Animal Health Business Overview
  22. 8.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  24. 8.4.5 Bayer Animal Health Recent Developments
  25. 8.5 Elanco Animal Health
  26. 8.5.1 Elanco Animal Health Company Information
  27. 8.5.2 Elanco Animal Health Business Overview
  28. 8.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  30. 8.5.5 Elanco Animal Health Recent Developments
  31. 8.6 Dechra Veterinary Products
  32. 8.6.1 Dechra Veterinary Products Company Information
  33. 8.6.2 Dechra Veterinary Products Business Overview
  34. 8.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
  36. 8.6.5 Dechra Veterinary Products Recent Developments
  37. 8.7 CEVA
  38. 8.7.1 CEVA Company Information
  39. 8.7.2 CEVA Business Overview
  40. 8.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
  42. 8.7.5 CEVA Recent Developments
  43. 8.8 Virbac
  44. 8.8.1 Virbac Company Information
  45. 8.8.2 Virbac Business Overview
  46. 8.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
  48. 8.8.5 Virbac Recent Developments
  49. 8.9 Norbrook Equine
  50. 8.9.1 Norbrook Equine Company Information
  51. 8.9.2 Norbrook Equine Business Overview
  52. 8.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
  54. 8.9.5 Norbrook Equine Recent Developments
  55. 8.10 Kyoritsu Seiyaku
  56. 8.10.1 Kyoritsu Seiyaku Company Information
  57. 8.10.2 Kyoritsu Seiyaku Business Overview
  58. 8.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
  60. 8.10.5 Kyoritsu Seiyaku Recent Developments
  61. 8.11 Vetoquinol
  62. 8.11.1 Vetoquinol Company Information
  63. 8.11.2 Vetoquinol Business Overview
  64. 8.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
  66. 8.11.5 Vetoquinol Recent Developments
  67. 8.12 Protexin Healthcare
  68. 8.12.1 Protexin Healthcare Company Information
  69. 8.12.2 Protexin Healthcare Business Overview
  70. 8.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
  72. 8.12.5 Protexin Healthcare Recent Developments
  73. 8.13 Audevard
  74. 8.13.1 Audevard Company Information
  75. 8.13.2 Audevard Business Overview
  76. 8.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
  78. 8.13.5 Audevard Recent Developments
  79. 8.14 Ouro Fino Saude
  80. 8.14.1 Ouro Fino Saude Company Information
  81. 8.14.2 Ouro Fino Saude Business Overview
  82. 8.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
  84. 8.14.5 Ouro Fino Saude Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
  2. 9.1.1 Equine Pharmaceuticals and Supplements Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Equine Pharmaceuticals and Supplements Sales Mode & Process
  6. 9.2 Equine Pharmaceuticals and Supplements Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Equine Pharmaceuticals and Supplements Distributors
  9. 9.2.3 Equine Pharmaceuticals and Supplements Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst